Image theory, perception and processing course

Course dates

Monday 23 (PM) - Tuesday 24 February 2026 

Venue

The Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB.

Course overview

The course is organised by the Joint Department of Physics of The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research.

This is a one and a half day course which covers the underpinning mathematics of medical imaging, comprising image formation, image processing techniques, human visual perception and image display techniques including three-dimensional methods.  The course has been extended to cover machine learning and AI imaging applications, including practical exercises which demonstrate the AI/ML concepts introduced in the lectures.

The material in this course is generally applicable to all types of imaging systems. Illustrations and examples from medical imaging will be used throughout including ultrasound, nuclear medicine, MRI, and x-ray CT.

The course is aimed at individuals who are undertaking formal training in medical physics. As well as being suitable for new entrants to the medical physics profession, it would also be of benefit to post-graduate students, post-doctoral research workers, representatives of allied commercial organisations and anyone wishing to deepen or re-establish their understanding of the mathematical techniques underpinning medical image formation, display and processing.

This is a CPD course approved by IPEM.

Provisional lecture list

  • Fundamentals of imaging
  • Perception and interpretation of medical images
  • Three-dimensional image display
  • Image processing techniques
  • Deep learning fundamentals
  • Responsible AI
  • Generative AI
  • Practical exercises

Registration & Course fees

Online Registration Form

Registration Form

All current course registration fees are given on our registration form.

The cost includes lunches and light refreshments. Electronic copies of the presentations and a certificate of attendance are provided.

You will be allocated a place on receipt of a completed registration form and a valid quoted payment reference/purchase order or online payment. We are unable to accept provisional bookings.

The number of participants is limited, so early booking is advised.  Applications from outside the UK are welcome.

Closing date for registrations – Friday 6 February 2026

Related documents

Provisional Timetable

Provisional Lecture Synopses

Map of Chelsea site

 

Contacts

Course Organiser: Dr Jamie Dormand

For registration details and any other queries contact:

Course Administrator: Mrs Jessica Keegan
IPEM_Approved_Logo_Black

Latest ICR News

How advances in microscopy are transforming structural biology at the ICR

07/08/25 - Robbie Lockyer

At The Institute of Cancer Research, London, our ability to visualise the intricate inner workings of cancer is going from strength to strength. Robbie Lockyer spoke with scientists using cutting-edge imaging techniques to uncover how these tools are helping us understand cancer in unprecedented detail.
See full story
Dame Stella Rimington
Dame Stella Rimington, former Chair of the ICR, dies aged 90

06/08/25

Dame Stella Rimington, who served as Chair of the Board of Trustees at The Institute of Cancer Research, London, from 1997 to 2005, died on 3 August 2025.
See full story
A picture of an MRI scanner
New MRI scan can spot tiny traces of blood cancer after treatment

04/08/25

Whole-body MRI scans provide powerful insights into treatment effectiveness and long-term outcomes for patients with myeloma, an incurable but treatable blood cancer.  Results from the iTIMM study led by The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London have shown that whole-body MRI scans (WB-MRI) can detect tiny traces of the disease, known as minimal residual disease (MRD), in the bone marrow after treatment. This can provide a crucial insight into how well patients with multiple myeloma are responding to treatment and whether they might relapse - offering a potential new standard in how this complex blood cancer is assessed. 
See full story
Small fragments, big impact: discovering the 'shearosomes' that drive cancer's spread

30/07/25

A collaborative study reveals an unexpected way cancer spreads through the body – by shedding tiny, previously unidentified fragments called shearosomes as tumour cells squeeze through narrow blood vessels. Shearosomes appear to actively influence their surroundings, supporting the growth of secondary tumours, offering new insights into how cancer spreads.
See full story